Current Environment:

Loren Walensky | Medical Services

Programs & Services


  • English

Loren Walensky | Education

Medical School

Johns Hopkins University School of Medicine

Baltimore, MD



Boston Combined Residency Program (BCRP)

Boston, MA


Pediatric Hematology-Oncology

Boston Children's Hospital/Dana-Farber Cancer Institute

Boston, MA

Loren Walensky | Certifications

  • American Board of Pediatrics (Hematology-Oncology)

Loren Walensky | Professional History

Dr. Loren Walensky received his MD and PhD degrees from Johns Hopkins University School of Medicine in 1997. He trained at the Boston Combined Residency Program in pediatrics, completed a fellowship in pediatric hematology-oncology at Dana-Farber and Boston Children's Hospital, and is board-certified in pediatric hematology/oncology. Dr. Walensky joined Dana-Farber as an attending physician in pediatric hematology/oncology in 2003 and founded his cancer chemical biology research laboratory in 2006. His research involves the development of highly specific and stable “stapled peptides” that preserve the structure of biologically-active peptide helices, maximizing their potential as novel tools to elucidate oncogenic pathways and as prototype therapies for cancer. A stapled peptide drug based on his research is currently undergoing clinical testing in a diversity of human cancers. Dr. Walensky is currently Principal Investigator and Attending Physician in the Department of Pediatric Oncology at the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center; Professor of Pediatrics at Harvard Medical School; and Director of the Harvard/MIT MD-PhD Program.

Loren Walensky | Publications